Sleuth identifies dozens of studies that used the wrong antibody

A UK-based independent molecular biologist named Sholto David has uncovered over 50 scientific studies that mistakenly used an incorrect antibody to detect a crucial protein linked to cell aging. The error involves the use of an antibody designed to target β-galactosidase from Escherichia coli bacteria rather than the mammalian version of the enzyme. These studies were published in recent years, and the mistake appears to have been made unintentionally. David first raised concerns about flawed antibody usage in early 2023, identifying hundreds of studies with similar errors. He later collaborated with another researcher to highlight issues with antibody validation images in the catalogues of Thermo Fisher Scientific, a major supplier of laboratory reagents based in Waltham, Massachusetts. His latest findings were shared publicly on the research-integrity blog For Better Science in mid-July. While it remains unclear how significantly these errors affect the validity of the studies, David suggests they could undermine the reliability of the data in certain cases. Antibodies play a vital role in biological research, enabling scientists to track specific proteins within complex cellular environments. However, they are also prone to misuse or mischaracterization. Researchers sometimes encounter difficulties replicating results even when using the same antibodies, and in some instances, the antibodies may bind to unintended proteins, leading to inaccurate conclusions. This issue is compounded by the lack of rigorous validation protocols for many commonly used antibodies. In the current case, David notes that researchers appear to have selected antibodies intended for detecting bacterial β-galactosidase instead of those suitable for mammalian cells. This choice is particularly problematic because β-galactosidase activity is considered a marker of cellular senescence, the state in which cells cease to divide yet remain metabolically active. Understanding senescence is critical for aging research, as accumulated senescent cells contribute to tissue dysfunction, chronic inflammation, and the secretion of harmful proteins. To study senescence, scientists rely on antibodies that specifically bind to mammalian β-galactosidase. Techniques such as immunostaining and western blotting allow researchers to visualize and quantify the presence of this enzyme, thereby identifying senescent cells. Although there is ongoing debate regarding the accuracy of this method, some researchers continue to use it due to its simplicity and widespread availability. David's investigation revealed that at least 54 studies cited the use of antibodies targeting E. coli-derived β-galactosidase. According to him, employing such antibodies to detect mammalian β-galactosidase is ineffective. “This is a big blunder,” he wrote on his blog, emphasizing the potential consequences of this oversight. Cross-species reactivity between antibodies is rare and lacks substantial theoretical or experimental support, making the use of bacterial-targeted antibodies in mammalian contexts highly questionable. Jennifer Byrne, a cancer researcher at the University of Sydney, points out that while some manufacturers acknowledge the possibility of cross-reactivity with other species, their disclaimers are typically vague and not backed by experimental confirmation. Most companies do not conduct thorough tests to verify whether their antibodies interact with proteins from different organisms, leaving researchers vulnerable to errors. As the field of biomedical research continues to expand, the reliance on high-throughput methods and artificial intelligence to analyze large datasets raises new challenges. If studies contain fundamental errors, such as the improper use of antibodies, it could lead to misleading conclusions and hinder progress in areas like drug discovery and therapeutic development. Addressing these issues requires greater transparency, standardized validation procedures, and increased scrutiny of the tools and materials used in modern research.